Compare GKOS & FAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | FAF |
|---|---|---|
| Founded | 1998 | 1889 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.3B |
| IPO Year | 2015 | N/A |
| Metric | GKOS | FAF |
|---|---|---|
| Price | $114.91 | $60.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $127.71 | $75.75 |
| AVG Volume (30 Days) | 647.8K | ★ 820.9K |
| Earning Date | 02-17-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 3.63% |
| EPS Growth | N/A | ★ 428.61 |
| EPS | N/A | ★ 4.65 |
| Revenue | $469,820,000.00 | ★ $7,087,600,000.00 |
| Revenue This Year | $31.33 | $19.11 |
| Revenue Next Year | $24.01 | $7.06 |
| P/E Ratio | ★ N/A | $13.03 |
| Revenue Growth | ★ 30.38 | 20.70 |
| 52 Week Low | $73.16 | $53.09 |
| 52 Week High | $163.71 | $68.64 |
| Indicator | GKOS | FAF |
|---|---|---|
| Relative Strength Index (RSI) | 61.49 | 42.74 |
| Support Level | $93.96 | $58.77 |
| Resistance Level | $115.00 | $63.07 |
| Average True Range (ATR) | 4.22 | 1.62 |
| MACD | -0.57 | -0.12 |
| Stochastic Oscillator | 98.88 | 37.35 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
First American Financial Corp is a financial services business providing insurance through segments: Title insurance and related services segment include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services; The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period; and The corporate segment includes investments in venture-stage companies, certain financing facilities and corporate services supporting the company's business operations.